RenalytixAI is a developer of artificial intelligence-enabled clinical diagnostic solutions for kidney health.
Renalytix AI has raised $9.4M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2025.
Renalytix AI's investors include Horizon Europe, DB Capital Partners, Christopher Mills, Timothy Scannell, Ann E. Berman.
Renalytix AI is headquartered in Penarth, United Kingdom.
RenalytixAI is a developer of artificial intelligence-enabled clinical diagnostic solutions for kidney health.
Renalytix AI is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Renalytix AI — Funding & Investors." VCBacked, September 26, 2025, https://www.vcbacked.co/company/renalytix-ai. Accessed September 29, 2026.
VCBacked. (2025). Renalytix AI — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/renalytix-ai
{{cite web |title=Renalytix AI — Funding & Investors |url=https://www.vcbacked.co/company/renalytix-ai |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated